Optics
← 2026-08-03 archive

ARCHIVED · 1 LEFT · 4 CENTER · 0 RIGHT · Aug 3, 1:19 AM

Different Spin

Astra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Fortune and The Straits Times describe the same event in different terms.

Archive
This is a stored Optics snapshot.It preserves the source map and wording analysis from 8/3/2026, 1:19:05 AM.

30-SECOND READ

What happenedU.K. pharmaceutical giant Astra Zeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
What changedThe left frames it as "Astra Zeneca said to have explored Bristol Myers merger". The center frames it as "Astra Zeneca holds talks with Bristol Myers Squibb on $512 billion megadeal: Report".
ConfidenceMedium. 3+ sources across at least two bias buckets with comparable news formats.
Archive healthLive match · 5 sources · 2 buckets · comparable news format

WORDING GAP

56WORDING GAP

5 sources · 2 bias buckets · Medium confidence

Still Watching. The left frames it as "Astra Zeneca said to have explored Bristol Myers merger". The center frames it as "Astra Zeneca holds talks with Bristol Myers Squibb on $512 billion megadeal: Report".

SOURCE MAP TIMELINE

Aug 2, 8:04 PM: The Straits Times joined the source map.

Aug 2, 8:13 PM: Bloomberg - Markets joined the source map.

Aug 2, 9:27 PM: Fortune joined the source map.

Aug 2, 10:17 PM: CNBC joined the source map.

Now: Wording Gap is 56/99 and story health is live match · 5 sources · 2 buckets · comparable news format.

ARCHIVED SOURCES

Center ·News report
CNBC2h ago

Astra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant Astra Zeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

Open source
Center ·News report
Financial Times1h ago

Astra Zeneca holds talks with Bristol Myers Squibb over $400bn tie-up

Deal would create world’s fourth-largest drugmaker by market value

Open source
Center-left ·News report
Fortune3h ago

Astra Zeneca said to have explored Bristol Myers merger

Bristol Myers Squibb, which has a $133 billion market capitalization, could provide Astra Zeneca with a bigger foothold in the US market.

Open source
Center ·News report
Bloomberg - Markets4h ago

Astra Zeneca Is Said to Have Explored Bristol Myers Merger

Astra Zeneca Plc has explored an acquisition of Bristol Myers Squibb Co., a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.

Open source
Center ·News report
The Straits Times4h ago

Astra Zeneca holds talks with Bristol Myers Squibb on $512 billion megadeal: Report

The deal could create one of the world’s biggest pharmaceutical groups with a combined value of nearly US$400 billion.

Open source